Nuveen
NAMS icon

Nuveen’s NewAmsterdam Pharma NAMS Stock Holding History

Nuveen’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.08K Buy
+209
New +$5.78K ﹤0.01% 4674

Other funds holding NAMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Medicxi Ventures Management
Medicxi Ventures Management St. Helier, Jersey $127M AUM 21.77% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Mizuho Markets Cayman
Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.12B AUM 114.77% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Peregrine Capital Management
Peregrine Capital Management Minneapolis, Minnesota $2.95B AUM 28.43% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM

Nuveen's NAMS Position: Q3 2026 in Review

Nuveen opened a new position in NewAmsterdam Pharma (NAMS) in Q3 2026: 209 shares worth $5.08K. The stake represents ﹤0.01% of the portfolio and ranks #4674 among its holdings.

66 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.

  • Nuveen held 209 shares of NewAmsterdam Pharma worth $5.08K as of Q3 2026.
  • NewAmsterdam Pharma was a new Nuveen position in Q3 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4674 holding.
  • 66 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.